He-Jing Wang - Concepedia

Concepedia

Author

He-Jing Wang

University of California, Los Angeles

Also Known As

H J Wang, He-Jing Wang, He-jing Wang, HeJing Wang

40

Publications

6.6K

Citations

32

H-Index

79

Concepts

All Affiliations

University of California, Los Angeles Saint John's Health Center Molecular Oncology (United States)Angeles Clinic and Research Institute University of Minnesota

HW

About

He-Jing Wang is an author at University of California, Los Angeles specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.5K
2	Engineering	3	3	219
3	Health Sciences	2	2	77
4	Public Health	1	1	89
5	Social Sciences	1	1	124

He-Jing Wang

×

39

Publications

6.6K

Citations

32

H-Index

	Year	Citations
Sentinel-Node Biopsy or Nodal Observation in Melanoma Donald L. Morton, John F. Thompson, Alistair J. Cochran, New England Journal of Medicine	2006	1.8K
Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma Donald L. Morton, John F. Thompson, Richard Essner, Annals of Surgery	1999	770
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer Gottfried E. Konecny, Chen Wang, Habib Hamidi, JNCI Journal of the National Cancer Institute Transcriptional ProfilingMolecular SubtypesTherapeutic RelevanceMedicinePathology	2014	397
Chemokine Receptor<i>CXCR4</i>Expression in Colorectal Cancer Patients Increases the Risk for Recurrence and for Poor Survival Joseph Kim, Hiroya Takeuchi, Stella Lam, Journal of Clinical Oncology	2005	376
Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease Joshua J. Zaritsky, Brian Young, He-Jing Wang, Clinical Journal of the American Society of Nephrology	2009	347
Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer Gottfried E. Konecny, Boris Winterhoff, Teodora Kolarova, Clinical Cancer Research	2011	296
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial Rhonda R. Voskuhl, He-Jing Wang, Tao Wu, The Lancet Neurology Relapsing-remitting Multiple SclerosisMedicineNeurological ProgressClinical TrialsPharmacotherapy	2015	201
Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis Masaru Shinozaki, Dave S.�B. Hoon, Armando E. Giuliano, Clinical Cancer Research	2005	169
Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy Takuji Mori, Steven O’Day, Naoyuki Umetani, Journal of Clinical Oncology	2005	167
Utility of Circulating <i>B-RAF</i> DNA Mutation in Serum for Monitoring Melanoma Patients Receiving Biochemotherapy Masaru Shinozaki, Steven O’Day, Minoru Kitago, Clinical Cancer Research	2007	161

Page 1